If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...

Experimental - This project is still in development, and not ready for the prime time. A minimal, secure Python interpreter written in Rust for use by AI. Monty avoids the cost, latency, complexity ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to supercharge its AI-driven drug discovery platform through an expanded ...

Recently, as I learned the news of young Tatiana Schlossberg’s passing from cancer, once again the words fight, battle, and courageous filled the headlines. They are words we hear often when cancer is ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

How does Python’s new native JIT stack up against PyPy? Is there life for machine learning applications outside of Python? And can we run our Python apps in WebAssembly yet? Keep reading for answers ...

Houston journalist Kate Murphy discusses the science behind human connection, which she delves into in her new book, “Why We Click.” Let's face it: the Internet age has been a dual-edge sword. Social ...

Women gather at a neighborhood square in Lilongwe, Malawi, on June 8 Women gather at a neighborhood square in Lilongwe, Malawi, on June 8Zafer Goder—Anadolu/Getty Images In Malawi, one in three women ...

This is a review of Truth: What It Is, How To Find It & Why It Still Matters. by Michael Shermer, forthcoming from Johns Hopkins University Press. Amidst claims of “fake news,” “alternative facts,” ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Recursion Pharmaceuticals, Inc. before investing. In this article, we go over a ...

Well before market open, prognosticator Priyanka Grover of JPMorgan Chase unit J.P. Morgan changed her Recursion rating. She now feels it's worthy of an overweight (buy, in other words), up one full ...